nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergoloid mesylate—DRD1—Parkinson's disease	0.518	0.587	CbGaD
Ergoloid mesylate—DRD2—Parkinson's disease	0.365	0.414	CbGaD
Ergoloid mesylate—DRD1—telencephalic ventricle—Parkinson's disease	0.0068	0.164	CbGeAlD
Ergoloid mesylate—DRD1—nerve—Parkinson's disease	0.00429	0.103	CbGeAlD
Ergoloid mesylate—DRD2—telencephalic ventricle—Parkinson's disease	0.00402	0.097	CbGeAlD
Ergoloid mesylate—DRD2—nerve—Parkinson's disease	0.00253	0.0611	CbGeAlD
Ergoloid mesylate—DRD2—hindbrain—Parkinson's disease	0.0019	0.0458	CbGeAlD
Ergoloid mesylate—DRD1—brainstem—Parkinson's disease	0.00184	0.0444	CbGeAlD
Ergoloid mesylate—DRD1—forebrain—Parkinson's disease	0.00178	0.0429	CbGeAlD
Ergoloid mesylate—SLCO2B1—forebrain—Parkinson's disease	0.00147	0.0355	CbGeAlD
Ergoloid mesylate—Dihydroergotamine—HTR1A—Parkinson's disease	0.00126	0.16	CrCbGaD
Ergoloid mesylate—DRD1—midbrain—Parkinson's disease	0.00117	0.0283	CbGeAlD
Ergoloid mesylate—DRD2—brainstem—Parkinson's disease	0.00109	0.0262	CbGeAlD
Ergoloid mesylate—SLCO2B1—medulla oblongata—Parkinson's disease	0.00106	0.0257	CbGeAlD
Ergoloid mesylate—DRD2—forebrain—Parkinson's disease	0.00105	0.0253	CbGeAlD
Ergoloid mesylate—DRD1—head—Parkinson's disease	0.00102	0.0246	CbGeAlD
Ergoloid mesylate—DRD1—nervous system—Parkinson's disease	0.000964	0.0233	CbGeAlD
Ergoloid mesylate—SLCO2B1—spinal cord—Parkinson's disease	0.000948	0.0229	CbGeAlD
Ergoloid mesylate—DRD1—central nervous system—Parkinson's disease	0.000928	0.0224	CbGeAlD
Ergoloid mesylate—SLCO2B1—head—Parkinson's disease	0.000842	0.0203	CbGeAlD
Ergoloid mesylate—Bromocriptine—HTR7—Parkinson's disease	0.000815	0.104	CrCbGaD
Ergoloid mesylate—SLCO2B1—nervous system—Parkinson's disease	0.000799	0.0193	CbGeAlD
Ergoloid mesylate—SLCO2B1—central nervous system—Parkinson's disease	0.000769	0.0186	CbGeAlD
Ergoloid mesylate—Bromocriptine—DRD3—Parkinson's disease	0.000766	0.0975	CrCbGaD
Ergoloid mesylate—Bromocriptine—DRD1—Parkinson's disease	0.000752	0.0957	CrCbGaD
Ergoloid mesylate—SLCO2B1—cerebellum—Parkinson's disease	0.000752	0.0181	CbGeAlD
Ergoloid mesylate—DRD1—brain—Parkinson's disease	0.000737	0.0178	CbGeAlD
Ergoloid mesylate—DRD2—midbrain—Parkinson's disease	0.000693	0.0167	CbGeAlD
Ergoloid mesylate—Ergotamine—HTR1A—Parkinson's disease	0.000648	0.0824	CrCbGaD
Ergoloid mesylate—Bromocriptine—HTR1A—Parkinson's disease	0.000625	0.0794	CrCbGaD
Ergoloid mesylate—SLCO2B1—brain—Parkinson's disease	0.000611	0.0147	CbGeAlD
Ergoloid mesylate—DRD2—head—Parkinson's disease	0.000601	0.0145	CbGeAlD
Ergoloid mesylate—DRD2—nervous system—Parkinson's disease	0.00057	0.0138	CbGeAlD
Ergoloid mesylate—Ergotamine—DRD2—Parkinson's disease	0.00055	0.0699	CrCbGaD
Ergoloid mesylate—DRD2—central nervous system—Parkinson's disease	0.000548	0.0132	CbGeAlD
Ergoloid mesylate—Dihydroergotamine—ABCB1—Parkinson's disease	0.000539	0.0685	CrCbGaD
Ergoloid mesylate—DRD2—cerebellum—Parkinson's disease	0.000536	0.0129	CbGeAlD
Ergoloid mesylate—Bromocriptine—DRD2—Parkinson's disease	0.00053	0.0674	CrCbGaD
Ergoloid mesylate—DRD2—brain—Parkinson's disease	0.000435	0.0105	CbGeAlD
Ergoloid mesylate—Ergotamine—HTR2A—Parkinson's disease	0.000425	0.054	CrCbGaD
Ergoloid mesylate—Bromocriptine—HTR2A—Parkinson's disease	0.00041	0.0521	CrCbGaD
Ergoloid mesylate—CYP3A4—nervous system—Parkinson's disease	0.000348	0.0084	CbGeAlD
Ergoloid mesylate—CYP3A4—central nervous system—Parkinson's disease	0.000335	0.00808	CbGeAlD
Ergoloid mesylate—Ergotamine—ABCB1—Parkinson's disease	0.000278	0.0353	CrCbGaD
Ergoloid mesylate—Bromocriptine—ABCB1—Parkinson's disease	0.000268	0.034	CrCbGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—HTR7—Parkinson's disease	0.000168	0.00249	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—DRD2—Parkinson's disease	0.000168	0.00249	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000168	0.00249	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000164	0.00244	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000163	0.00242	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000163	0.00241	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000161	0.00238	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000159	0.00235	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—PDYN—Parkinson's disease	0.000155	0.00229	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000153	0.00227	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000152	0.00225	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000148	0.0022	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000145	0.00215	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—DRD1—Parkinson's disease	0.000145	0.00215	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—GRM5—Parkinson's disease	0.000144	0.00213	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000143	0.00212	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000142	0.0021	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—DRD3—Parkinson's disease	0.00014	0.00208	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000139	0.00207	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000138	0.00204	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000138	0.00204	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000137	0.00203	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—GRM4—Parkinson's disease	0.000135	0.002	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GPR37—Parkinson's disease	0.000135	0.002	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000135	0.002	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000133	0.00197	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000132	0.00196	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000131	0.00194	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00013	0.00193	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—TH—Parkinson's disease	0.000129	0.00191	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—PENK—Parkinson's disease	0.000128	0.00189	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—HTR7—Parkinson's disease	0.000127	0.00188	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000126	0.00186	CbGpPWpGaD
Ergoloid mesylate—DRD2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000124	0.00183	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000123	0.00183	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000123	0.00182	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000122	0.00181	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000121	0.0018	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000121	0.00179	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000119	0.00176	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000118	0.00175	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000118	0.00175	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000118	0.00175	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—PDYN—Parkinson's disease	0.000117	0.00173	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000115	0.0017	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000112	0.00167	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000112	0.00166	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—GRM5—Parkinson's disease	0.000109	0.00161	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000108	0.0016	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000106	0.00157	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000105	0.00156	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000105	0.00156	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—TAC1—Parkinson's disease	0.000105	0.00155	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000104	0.00154	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000104	0.00154	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GRK5—Parkinson's disease	0.000102	0.00151	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000102	0.00151	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GPR37—Parkinson's disease	0.000102	0.00151	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000102	0.00151	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000101	0.00149	CbGpPWpGaD
Ergoloid mesylate—SLCO2B1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000101	0.00149	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—DRD3—Parkinson's disease	9.93e-05	0.00147	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	9.84e-05	0.00146	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	9.64e-05	0.00143	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VPS35—Parkinson's disease	9.61e-05	0.00142	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PENK—Parkinson's disease	9.56e-05	0.00142	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	9.45e-05	0.0014	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	9.44e-05	0.0014	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	9.32e-05	0.00138	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PPP1R1B—Parkinson's disease	9.31e-05	0.00138	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—ADORA2A—Parkinson's disease	9.24e-05	0.00137	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GRM4—Parkinson's disease	9.16e-05	0.00136	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—DRD2—Parkinson's disease	8.98e-05	0.00133	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—HTR7—Parkinson's disease	8.98e-05	0.00133	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	8.9e-05	0.00132	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.87e-05	0.00131	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PDYN—Parkinson's disease	8.75e-05	0.0013	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PENK—Parkinson's disease	8.68e-05	0.00129	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	8.49e-05	0.00126	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	8.42e-05	0.00125	CbGpPWpGaD
Ergoloid mesylate—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.26e-05	0.00122	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—GRM5—Parkinson's disease	8.13e-05	0.0012	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	8.01e-05	0.00119	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GPR37—Parkinson's disease	7.96e-05	0.00118	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—DGKQ—Parkinson's disease	7.96e-05	0.00118	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PDYN—Parkinson's disease	7.94e-05	0.00118	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	7.89e-05	0.00117	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	7.74e-05	0.00115	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	7.71e-05	0.00114	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	7.62e-05	0.00113	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	7.5e-05	0.00111	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—GRM5—Parkinson's disease	7.38e-05	0.00109	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PPP1R1B—Parkinson's disease	7.28e-05	0.00108	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	7.28e-05	0.00108	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VPS35—Parkinson's disease	7.25e-05	0.00107	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	7.22e-05	0.00107	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—EDN1—Parkinson's disease	7.19e-05	0.00107	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.13e-05	0.00106	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	6.92e-05	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.91e-05	0.00102	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	6.78e-05	0.001	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	6.6e-05	0.000978	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PENK—Parkinson's disease	6.56e-05	0.000971	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—MAPK8—Parkinson's disease	6.4e-05	0.000948	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RIT2—Parkinson's disease	6.36e-05	0.000943	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR ligand binding—HTR2A—Parkinson's disease	6.29e-05	0.000932	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	6.28e-05	0.00093	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.26e-05	0.000927	CbGpPWpGaD
Ergoloid mesylate—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.24e-05	0.000924	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.17e-05	0.000914	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	6.14e-05	0.000909	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GRK5—Parkinson's disease	6.03e-05	0.000894	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GPR37—Parkinson's disease	6.01e-05	0.00089	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	6.01e-05	0.00089	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	6e-05	0.000889	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	6e-05	0.000888	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—TAC1—Parkinson's disease	5.91e-05	0.000875	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	5.72e-05	0.000848	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.65e-05	0.000836	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—DRD3—Parkinson's disease	5.61e-05	0.000831	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	5.57e-05	0.000826	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	5.5e-05	0.000814	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—HTR1A—Parkinson's disease	5.45e-05	0.000807	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	5.43e-05	0.000804	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GRM4—Parkinson's disease	5.41e-05	0.000802	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—TAC1—Parkinson's disease	5.36e-05	0.000795	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.24e-05	0.000776	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.22e-05	0.000773	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PENK—Parkinson's disease	5.13e-05	0.00076	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAG—Parkinson's disease	5.13e-05	0.00076	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—DRD3—Parkinson's disease	5.1e-05	0.000755	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—HTR7—Parkinson's disease	5.07e-05	0.000752	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—DRD2—Parkinson's disease	5.07e-05	0.000752	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	4.83e-05	0.000715	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RIT2—Parkinson's disease	4.8e-05	0.000712	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.76e-05	0.000705	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	4.75e-05	0.000703	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.74e-05	0.000703	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	4.74e-05	0.000702	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.72e-05	0.000699	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.71e-05	0.000698	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PDYN—Parkinson's disease	4.69e-05	0.000695	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.68e-05	0.000693	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.66e-05	0.00069	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—DRD2—Parkinson's disease	4.61e-05	0.000683	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—HTR7—Parkinson's disease	4.61e-05	0.000683	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GRK5—Parkinson's disease	4.55e-05	0.000675	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	4.53e-05	0.000671	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	4.46e-05	0.000661	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GFAP—Parkinson's disease	4.41e-05	0.000654	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	4.37e-05	0.000648	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GRM5—Parkinson's disease	4.36e-05	0.000646	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.34e-05	0.000643	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.28e-05	0.000634	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	4.24e-05	0.000628	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	4.11e-05	0.000609	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GRM4—Parkinson's disease	4.09e-05	0.000605	CbGpPWpGaD
Ergoloid mesylate—DRD1—Circadian rythm related genes—IL6—Parkinson's disease	4.08e-05	0.000605	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—EDN1—Parkinson's disease	4.06e-05	0.000602	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	4.05e-05	0.0006	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	3.97e-05	0.000588	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.96e-05	0.000586	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PENK—Parkinson's disease	3.87e-05	0.000574	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAG—Parkinson's disease	3.87e-05	0.000574	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	3.85e-05	0.00057	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	3.83e-05	0.000568	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGF20—Parkinson's disease	3.82e-05	0.000567	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADORA2A—Parkinson's disease	3.71e-05	0.000549	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—EDN1—Parkinson's disease	3.69e-05	0.000547	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	3.59e-05	0.000532	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.55e-05	0.000527	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PDYN—Parkinson's disease	3.54e-05	0.000525	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	3.48e-05	0.000515	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INSR—Parkinson's disease	3.42e-05	0.000507	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GFAP—Parkinson's disease	3.33e-05	0.000493	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GRM5—Parkinson's disease	3.29e-05	0.000488	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGB—Parkinson's disease	3.23e-05	0.000479	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—HTR2A—Parkinson's disease	3.23e-05	0.000478	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HTR1A—Parkinson's disease	3.22e-05	0.000477	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TAC1—Parkinson's disease	3.17e-05	0.00047	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	3.08e-05	0.000457	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ND3—Parkinson's disease	3.08e-05	0.000456	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.08e-05	0.000456	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	3.07e-05	0.000454	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—DRD3—Parkinson's disease	3.01e-05	0.000446	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.89e-05	0.000428	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—OMD—Parkinson's disease	2.89e-05	0.000428	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGF20—Parkinson's disease	2.89e-05	0.000428	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRBK1—Parkinson's disease	2.81e-05	0.000416	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	2.8e-05	0.000415	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	2.79e-05	0.000413	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.74e-05	0.000406	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HTR7—Parkinson's disease	2.72e-05	0.000403	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—DRD2—Parkinson's disease	2.72e-05	0.000403	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.68e-05	0.000398	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.62e-05	0.000387	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INSR—Parkinson's disease	2.58e-05	0.000383	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGB—Parkinson's disease	2.44e-05	0.000362	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	2.44e-05	0.000361	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	2.43e-05	0.00036	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TAC1—Parkinson's disease	2.39e-05	0.000354	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—DRD1—Parkinson's disease	2.35e-05	0.000348	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—DBH—Parkinson's disease	2.33e-05	0.000345	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GBA—Parkinson's disease	2.33e-05	0.000345	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.33e-05	0.000345	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF2—Parkinson's disease	2.28e-05	0.000338	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—DRD3—Parkinson's disease	2.27e-05	0.000337	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	2.21e-05	0.000327	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EDN1—Parkinson's disease	2.18e-05	0.000323	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	2.12e-05	0.000314	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HTR7—Parkinson's disease	2.06e-05	0.000304	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NGF—Parkinson's disease	2e-05	0.000297	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	1.91e-05	0.000282	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOE—Parkinson's disease	1.77e-05	0.000263	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.72e-05	0.000255	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—DDC—Parkinson's disease	1.71e-05	0.000253	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.67e-05	0.000247	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.65e-05	0.000244	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.62e-05	0.000239	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INS—Parkinson's disease	1.51e-05	0.000224	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.51e-05	0.000224	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.45e-05	0.000216	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.44e-05	0.000213	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.44e-05	0.000213	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOE—Parkinson's disease	1.34e-05	0.000198	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INS—Parkinson's disease	1.14e-05	0.000169	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CASP3—Parkinson's disease	1.13e-05	0.000167	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL6—Parkinson's disease	1.12e-05	0.000166	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.07e-05	0.000159	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.05e-05	0.000156	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	1.04e-05	0.000153	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.79e-06	0.000145	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.68e-06	0.000143	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TH—Parkinson's disease	9.54e-06	0.000141	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.16e-06	0.000136	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CASP3—Parkinson's disease	8.51e-06	0.000126	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL6—Parkinson's disease	8.46e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—COMT—Parkinson's disease	8.11e-06	0.00012	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.07e-06	0.00012	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.05e-06	0.000119	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.96e-06	0.000118	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	7.82e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.64e-06	0.000113	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.42e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.1e-06	0.000105	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL6—Parkinson's disease	6.62e-06	9.8e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.56e-06	9.71e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOE—Parkinson's disease	6.1e-06	9.04e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—INS—Parkinson's disease	5.21e-06	7.72e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL6—Parkinson's disease	5e-06	7.4e-05	CbGpPWpGaD
